Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.

The Lancet. Microbe·2026
Same author

Prospective multicentre study of upper respiratory mucosal transcriptomics reveals two major endotypes of critically ill COVID-19 patients.

Communications medicine·2026
Same author

Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Hepatitis C virus elimination: So close, so far?

Antiviral research·2026
Same author

Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D).

Open forum infectious diseases·2026
Same journal

Tularemia-associated septic shock with pneumonia, lung abscesses, and pleural effusion leading to multiorgan failure: Is Francisella tularensis still a deadly pathogen in the antibiotic era? A case report.

Diagnostic microbiology and infectious disease·2026
Same journal

Impact of Xpert® MRSA/SA blood culture PCR test on antimicrobial utilization at a large teaching hospital.

Diagnostic microbiology and infectious disease·2026
Same journal

Disseminated Mucormycosis and monoclonal gammopathy in a young sarcoidosis patient following COVID-19: A rare case report.

Diagnostic microbiology and infectious disease·2026
Same journal

Human septic arthritis caused by Spiroplasma turonicum.

Diagnostic microbiology and infectious disease·2026
Same journal

Enhanced stability of RPA-CRISPR-Cas12a system for respiratory pathogen detection using Trehalose-Carboxymethyl Chitosan Lyoprotectant.

Diagnostic microbiology and infectious disease·2026
Same journal

Avian influenza H5N1: A warning signal for the next influenza pandemic.

Diagnostic microbiology and infectious disease·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.6K

Performance of the ELITe InGenius system for hepatitis B virus DNA quantification.

Delphine Rosse1, Olivia Garrigou1, Valérie Ortonne1

  • 1French National Reference Center for Hepatitis B, C and delta Viruses, Department of Virology, Hôpital Henri Mondor, Créteil, France; INSERM U955, Créteil, France.

Diagnostic Microbiology and Infectious Disease
|September 8, 2025
PubMed
Summary
This summary is machine-generated.

The ELITe InGenius System with the HBV ELITe MGB Kit accurately quantifies hepatitis B virus (HBV) DNA. This reliable method aids in diagnosing HBV infection and monitoring treatment effectiveness in patients.

Keywords:
DiagnosisHBV DNAMonitoringReal-time PCRViral hepatitis

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

18.8K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.9K

Related Experiment Videos

Last Updated: Jan 18, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.6K
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

18.8K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.9K

Area of Science:

  • Virology
  • Molecular Diagnostics
  • Clinical Chemistry

Background:

  • Hepatitis B virus (HBV) DNA quantification is crucial for managing HBV infection.
  • Accurate measurement guides diagnosis, prognosis, and treatment monitoring.
  • The ELITe InGenius System offers automated molecular diagnostic capabilities.

Purpose of the Study:

  • To evaluate the analytical and clinical performance of the ELITe InGenius System for HBV DNA quantification.
  • To assess the suitability of the HBV ELITe MGB Kit for routine clinical use.
  • To validate the system's accuracy and precision across its dynamic range.

Main Methods:

  • Analytical and clinical performance evaluation of the ELITe InGenius System and HBV ELITe MGB Kit.
  • Testing of 377 archived EDTA plasma or serum specimens.
  • Comparison with the cobas HBV Test for correlation analysis.

Main Results:

  • The HBV ELITe MGB Kit demonstrated linear quantification of HBV DNA with high precision.
  • 100% specificity was observed.
  • Satisfactory correlation was found with the cobas HBV Test, including patients on antiviral therapy.

Conclusions:

  • The ELITe InGenius System and HBV ELITe MGB Kit are suitable for detecting and quantifying HBV DNA.
  • The system provides reliable results across the entire quantification dynamic range.
  • This assay supports clinical decisions for HBsAg-positive patients.